Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cytosorbents Cor (NQ: CTSO )

3.400 +0.090 (+2.72%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cytosorbents Cor

CytoSorbents This Week to Host its Virtual Annual Stockholders Meeting and to Present at the Jefferies Healthcare Conference
From CytoSorbents
Via GlobeNewswire
CytoSorbents Reports First Quarter 2023 Results
Pivotal U.S. and Canada STAR-T Trial enrollment enters the last third of the study. Strong customer demand from Q4 2022 continued into Q1 2023, with current expectation of overall sales growth in 2023 
From CytoSorbents
Via GlobeNewswire
CytoSorbents to Report First Quarter 2023 Operating and Financial Results
From CytoSorbents
Via GlobeNewswire
CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
From CytoSorbents
Via GlobeNewswire
CytoSorbents Announces Board Chairman Al W. Kraus To Retire
From CytoSorbents
Via GlobeNewswire
Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation
From CytoSorbents
Via GlobeNewswire
CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)
From CytoSorbents
Via GlobeNewswire
CytoSorbents Comments on Bank Exposure and Diversified Cash Position
From CytoSorbents
Via GlobeNewswire
CytoSorbents Reports Fourth Quarter and Full Year 2022 Results
From CytoSorbents
Via GlobeNewswire
New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time
From CytoSorbents
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.